Cents, I think we may see partnership(s) in the not too distant future, from the PR:
"Having SAB members such as Santosh Kesari and Francesco Marincola, who are at the forefront of cancer immunotherapy, significantly positions us to accelerate the development of our new approach which targets the "Achille's Heel of cancer."